LOS ANGELES—Daybreak, a sleep apnea solutions company, has joined Parachute Health, an e-prescribing platform for home medical equipment (HME). Daybreak said this marks its first entry into e-prescribing and makes it available to the more than 300,000 clinicians and prescribers and 3,000 HME provider locations nationwide who use Parachute Health.
Sleep
SAN DIEGO—Resmed, a health technology company focused on sleep, breathing and care delivered in the home, announced a new collaboration with 23XI Racing and its NASCAR Cup Series driver Tyler Reddick to encourage more people to recognize the signs of sleep apnea and seek diagnosis and treatment.
SAN DIEGO—Resmed announced that Carol Burt will become lead director on Sunday, Nov. 15. She will succeed Ron Taylor, Resmed's current lead director, who is not standing for reelection at the company's annual meeting on Nov. 18 and will retire after more than 21 years of service to the company.
NEW YORK—Cathay Capital announced the launch of ReDream Brands, a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings together four of the industry’s most recognized direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com, creating a platform for cash-pay obstructive sleep apnea (OSA) customers across North America.
SAN DIEGO—Resmed and smart ring maker ŌURA announced they are partnering to expand access to sleep health education and pathways to care, helping more people sleep better and improve their overall health.
MURRYSVILLE, Pennsylvania—Philips, a provider of sleep health technology, announced that Philips Respironics DreamStation BiPAP AVAPS devices are available for sale in the United States for new set-ups for patients with obstructive sleep apnea (OSA) and respiratory impairment, who are both >7 years of age and weighing 40-66 pounds.
SAN DIEGO, California—Resmed, a provider in health technology focused on sleep, breathing and care delivered in the home, announced the appointment of Salli Schwartz as chief investor relations officer, effective April 21, 2025. In this role, Schwartz will lead Resmed's global investor relations function and report to Mick Farrell, chairman of the board and CEO.
